Innovent Bio

formerly Innovent BiologicsIPO

innovent

Public · Suzhou, China · Founded 2011 · $740.0M raised

Headquarters
Suzhou
Employees
5001–10000
Founded
2011
Business Model
B2B
Total Funding
$740.0M
Last Round
$80.0M Venture RoundJan 2025
Rounds
7
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 8 funding rounds and 14 investors for this company. The full record is or through the API.

About

Innovent Biologics is a leading biopharmaceutical company founded in 2011 with the mission to provide high-quality biologics that are affordable to all. Through its hallmark integrated approach, state-of-the-art manufacturing facilities, and strategic collaborations, the company is involved in every stage of a drug's lifecycle, from discovery to development to commercialization, building robust pipelines for innovative drugs that treat cancer and other major diseases.

Summary

Innovent Bio is a Biotech company based in Suzhou, China, founded in 2011. It has raised $740.0M in total across 7 rounds, most recently a $80.0M Venture Round in Jan 2025. Investors include Legend Capital, Capital Group Private Markets and Eli Lilly.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Venture RoundIPO Preparation RoundJan 2025
$80.0M

Sign up to see all 8 events

Funding: Series A through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Innovent Bio on Indexed.vc
<a href="https://indexed.vc/companies/innovent-bio"><img src="https://indexed.vc/api/badge/company/innovent-bio" alt="Innovent Bio on Indexed.vc" width="260" height="76" /></a>